Suppr超能文献

肌浆网腔面的肌肉特异性GSTM2-2修饰兰尼碱受体离子通道活性。

Muscle-specific GSTM2-2 on the luminal side of the sarcoplasmic reticulum modifies RyR ion channel activity.

作者信息

Wei Lan, Abdellatif Yasser A, Liu Dan, Kimura Takashi, Coggan Marjorie, Gallant Esther M, Beard Nicole A, Board Philip G, Dulhunty Angela F

机构信息

Division of Molecular Bioscience, John Curtin School of Medical Research, Australian National University, PO Box 334, Canberra City, ACT 2601, Australia.

出版信息

Int J Biochem Cell Biol. 2008;40(8):1616-28. doi: 10.1016/j.biocel.2007.12.019. Epub 2008 Jan 20.

Abstract

We show that a glutathione transferase (GST) protein, which is recognised by an antibody against the muscle-specific human GSTM2-2 (hGSTM2-2), is associated with the lumen of the sarcoplasmic reticulum (SR) of cardiac muscle, but not skeletal muscle. We further show that hGSTM2-2 modifies both cardiac and skeletal ryanodine receptor (RyR) activity when it binds to the luminal domain of the RyR channel complex. The properties of hGSTM2-2 were compared with those of the calsequestrin (CSQ), a Ca(2+) binding protein also present in the lumen of the SR which, like GSTM2-2, contains a thioredoxin-fold structure and modifies RyR activity (Wei, L., Varsanyi, M., Dulhunty, A. F., Beard, N. A. (2006). The Biophysical Journal, 91, 1288-1301). The glutathione transferase activity of hGSTM2-2 is strong, while CSQ is essentially inactive. Conversely CSQ is a strong Ca(2+) binder, but hGSTM2-2 is not. The effects of luminal hGSTM2-2 on RyR activity differ from those of CSQ in that hGSTM2-2 activates RyRs by increasing their open probability and conductance and the effects are independent of luminal Ca(2+) concentration. The results suggest that GSTM2-2 can interact with specific luminal sites on the RyR complex and that the interaction is likely to be within the pore of the RyR channel. The differences between the effects of CSQ and hGSTM2-2 suggest that the thioredoxin fold is not a major determinant of the luminal actions of either protein. The results indicate that GSTM2-2 is a novel luminal regulator of the RyR channels in the heart.

摘要

我们发现,一种谷胱甘肽S-转移酶(GST)蛋白,可被抗肌肉特异性人GSTM2-2(hGSTM2-2)抗体识别,它与心肌肌浆网(SR)的管腔相关,但与骨骼肌的肌浆网管腔无关。我们进一步表明,hGSTM2-2与兰尼碱受体(RyR)通道复合物的管腔结构域结合时,会改变心肌和骨骼肌兰尼碱受体(RyR)的活性。将hGSTM2-2的特性与肌集钙蛋白(CSQ)的特性进行了比较,CSQ是一种也存在于肌浆网管腔中的Ca(2+)结合蛋白,与GSTM2-2一样,含有硫氧还蛋白折叠结构并能改变RyR活性(Wei, L., Varsanyi, M., Dulhunty, A. F., Beard, N. A. (2006). The Biophysical Journal, 91, 1288 - 1301)。hGSTM2-2的谷胱甘肽转移酶活性很强,而CSQ基本无活性。相反,CSQ是一种很强的Ca(2+)结合蛋白,但hGSTM2-2不是。管腔内hGSTM2-2对RyR活性的影响与CSQ不同,hGSTM2-2通过增加RyR的开放概率和电导来激活RyR,且这些影响与管腔内Ca(2+)浓度无关。结果表明,GSTM2-2可与RyR复合物上特定的管腔位点相互作用,且这种相互作用可能发生在RyR通道的孔内。CSQ和hGSTM2-2作用的差异表明,硫氧还蛋白折叠不是这两种蛋白管腔作用的主要决定因素。结果表明,GSTM2-2是心脏中RyR通道一种新的管腔调节因子。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验